Follow us :

Hyamed Shines Brightly at Dubai Derma 2024 Exhibition

publisherLaboratories Hyamed SA

time2024/03/13

✅Date: 5-7, March 2024
✅Booth: No. 7A11
✅Venue: Dubai World Trade Centre (DWTC), UAE
Over the years, Dubai Derma has emerged as the largest scientific skincare gathering in the Middle East, North Africa & the Indian Subcontinent region. The 23rd edition of Dubai Derma will bring together the skincare specialists, industry leaders, and key decision-makers from the region and across the world.
As a long-time sponsor of Dubai Derma, Hyamed created some surprises this year.

Firstly, Hyamed has prepared a massive 54㎡ booth for this exhibition, capable of accommodating both new and existing customers. The Hyamed team is also professionally and patiently serving them, assisting them in finding the desired products and solutions more effectively.

Furthermore, Hyamed has brought its innovative products and cutting-edge technologies to the visitors and the medical aesthetics industry at the exhibition.

As we all knows, Hyamed has always been a leader in the field of hyaluronic acid fillers, with over 20 kinds of products sold to more than 70 countries worldwide.

Currently, Hyamed has also made achievements in the fields of regenerative fillers and Mesotherapy Solutions.

CaHA Lido Injectable Facial Implant and PLLA Injectable Poly-L-Lactic Acid Filler are the new products launched by Hyamed in 2023, which have been warmly welcomed by the medical aesthetics market for their innovative technology and high quality.

Our Swiss R&D team has also made significant progress in the development of Mesotherapy Solutions, with 18 new products launched in 2023, targeting skin issues on various body parts including the scalp, effectively improving the skin.

Super Hydra is a non-cross-linked hyaluronic acid filler, containing 7 amino acids and 2 peptides. After injection using Switzerland's Ten Point Lift technique, it can effectively lift aging and sagging skin tissue, helping patients restore firm skin.

Volumizer is one of the few dermal fillers on the market produced using monophasic cross-linking technology, used to increase tissue volume in areas of the face lacking tissue, especially suitable for chin augmentation. In 2024, this product will obtain CE certification, benefiting patients in the European market.

Hyamed never stops in its journey to create beauty. Choose us and join us in spreading this beauty to every corner of the world.